VBI Vaccines Inc

(NASDAQ:VBIV)

Latest On VBI Vaccines Inc (VBIV):

Date/Time Type Description Signal Details
2023-05-15 16:15 ESTNewsVBI Vaccines GAAP EPS of -$3.22, revenue of $0.49MN/A
2023-04-04 22:00 ESTNewsVBI Vaccines falls 40% on portfolio reorganization, reverse stock splitN/A
2023-03-13 20:20 ESTNewsVBI Vaccines reports FY resultsN/A
2022-12-08 15:37 ESTNewsVBI Vaccines wins Health Canada approval for hepatitis B vaccine PreHevbrioN/A
2022-11-11 00:49 ESTNewsVBI Vaccines GAAP EPS of -$0.10 misses by $0.02, revenue of $0.32M misses by $0.97MN/A
2022-10-12 11:23 ESTNewsVBI Vaccines, Agenus to examine VBI-1901 + balstilimab combo for glioblastomaN/A
2022-09-23 00:55 ESTNewsVBI Vaccines: Recent Updates Have Fortified My Long-Term OutlookN/A
2022-09-15 23:49 ESTNewsVBI Vaccines gets up to $100M debt funding from K2 HealthVenturesN/A
2022-09-08 19:05 ESTNewsValneva, VBI Vaccines in pact to launch Hep B vaccine in EuropeN/A
2022-08-27 04:18 ESTNewsVBI Vaccines down 10% on $300M mixed shelf offering; also ends two equity offeringsN/A
2022-08-08 10:29 ESTNewsVBI Vaccines Non-GAAP EPS of -$0.09 misses by $0.02, revenue of $0.35M misses by $0.35MN/A
2022-08-08 10:29 ESTNewsVBI Vaccines stock slumps 10% on Q2 miss, net loss widens on forex impactN/A
2022-06-28 12:04 ESTNewsVBI Vaccines boasts of new follow-up data for hepatitis B vaccine over GSK rivalN/A
2022-06-23 03:25 ESTNewsVBI outlines next steps for brain cancer vaccine candidate after orphan drug designationN/A
2022-06-17 20:57 ESTNewsVBI Vaccines: Recent VBI-1901 Data Supports My Bull ThesisN/A
2022-06-17 20:57 ESTNewsVBI Vaccines, Hepion win FDA orphan drug designations for cancer candidatesN/A
2022-06-07 03:37 ESTNewsVBI Vaccines updated phase 2 glioblastoma data shows continued overall survival benefitN/A
2022-06-01 22:25 ESTNewsVBI Vaccines hepatitis B shot PreHevbri gets approval in UKN/A
2022-05-09 18:29 ESTNewsVBI Vaccines GAAP EPS of -$0.08 in-line, revenue of $0.13M beats by $0.04MN/A
2022-05-02 10:26 ESTNewsVBI Vaccines stock rises as hepatitis B shot PreHevbri gets approval in EUN/A
2022-03-29 14:22 ESTNewsVBI Vaccines launches Hepatitis B vaccine in U.S.N/A
2022-03-07 10:16 ESTNewsVBI Vaccines GAAP EPS of $0.27 beats by $0.54, revenue of $0.63M misses by $0.17MN/A
2022-02-25 16:07 ESTNewsVBI Vaccines wins European recommendation for Hep B vaccineN/A
2022-02-24 03:34 ESTNewsVBI Vaccines wins CDC recommendation for Hep B vaccineN/A
2021-12-30 03:13 ESTNewsVBI Vaccines a buy at Jefferies on vaccine technology platform; sees 171% upsideN/A
2021-12-09 09:52 ESTNewsVBI Vaccines files new drug submission for 3-antigen hepatitis B vaccine in CanadaN/A
2021-12-01 11:02 ESTNewsVBI Vaccines wins FDA approval for Hepatitis B vaccineN/A
2021-11-08 20:54 ESTNewsVBI Vaccines EPS beats by $0.01, misses on revenueN/A
2021-10-31 13:10 ESTNewsVBI Vaccines: Hepatitis Vaccine Approval Can Be A Catalyst For >$1bn ValuationN/A
2021-10-13 10:08 ESTNewsVBI Vaccines reports Phase 3 data from prophylactic 3-antigen HBV vaccine study in medical journalN/A
2021-09-30 01:37 ESTNewsVBI Vaccines kicks off Phase 1b study of VBI-2905, reports preclinical data in Covid variantsN/A
2021-09-04 00:35 ESTNewsVBI Vaccines dips after filing for $125M at-the-market offeringN/A
2021-08-03 20:37 ESTNewsVBI Vaccines net loss widens amid pre-commercialization activities for Hep B vaccineN/A
2021-08-03 01:41 ESTNewsVBI Vaccines EPS misses by $0.01, misses on revenueN/A
2021-07-22 07:04 ESTNewsVBI Vaccines shares rise after FDA grants VBI-1901 'fast track' statusN/A
2021-07-22 06:47 ESTNewsVBI Vaccines present positive VBI-2601 data in chronic hepatitis B at EASL 2021N/A
2021-07-22 06:41 ESTNewsVBI Vaccines shares rise on data from early-stage COVID-19 vaccine studyN/A
2021-07-22 06:24 ESTNewsVBI Vaccines: Turning My Focus To VBI-1901N/A
2021-04-29 00:24 ESTNewsVBI Vaccines reports preclinical VBI-2902 data in COVID-19N/A
2021-04-29 00:23 ESTNewsVBI Vaccines: Reloading My Position Ahead Of Transformative CatalystsN/A
2021-04-13 03:41 ESTNewsVBI’s hepatitis B candidate shows robust response in Phase 1/2 studyN/A
2021-03-10 21:01 ESTNewsVBI Vaccine shares gain on CEPI collab to advance vaccine against COVID-19 variantsN/A
2021-03-10 01:28 ESTNewsVBI Vaccines shares rise on enrollment in study of COVID-19 vaccine candidate, VBI-2902N/A
2021-03-03 20:58 ESTFinancialsCompany financials have been released.Neutral
2021-03-03 12:39 ESTEarnings EstimateAn EPS average of -$0.10 is estimated for the 2022 year.Sell
2021-03-03 12:39 ESTEarnings EstimateAn EPS average of -$0.07 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-02 21:09 ESTNewsVBI Vaccines EPS misses by $0.15, misses on revenueN/A
2021-02-26 16:32 ESTAnalyst RatingThe Analyst Target Price has increased from $6.5 to $6.6.Buy
2021-02-18 23:57 ESTNewsCOVID-19 vaccine developers to benefit from supply constraints and uneven distributionN/A
2021-02-10 20:33 ESTNewsVBI shares turn higher following talk of 'pancoronavirus' vaccineN/A

About VBI Vaccines Inc (VBIV):

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the presentation of viruses to elicit a human immune system. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial. The company also develops coronavirus vaccine candidates, such as VBI-2902 and VBI-2901. In addition, it engages in the development of vaccine platforms and products for licensing to pharmaceutical companies and biotechnology companies. The company primarily serves physicians and pharmacists through direct sales. It has collaboration and license agreements with Brii Biosciences Limited; and GlaxoSmithKline Biologicals S.A. The company also has a collaboration with the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. VBI Vaccines Inc. has collaboration with Coalition For Epidemic Preparedness Innovations to advance vaccine candidates against Covid-19 variants. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts.

VBIV Quotes by TradingView

See Advanced Chart

General

  • Name VBI Vaccines Inc
  • Symbol VBIV
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 127
  • Last Split Factor1:40
  • Last Split Date2016-05-02
  • Fiscal Year EndDecember
  • IPO Date1995-08-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.vbivaccines.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 687.11
  • Price/Book (Most Recent Quarter) 4.94
  • Enterprise Value Revenue 704.21
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.26
  • Next Year EPS Estimate -$0.11
  • Next Quarter EPS Estimate -$0.06
  • Operating Margin -4111%
  • Return on Assets -16%
  • Return on Equity -36%
  • Revenue 1.06 million
  • Earnings Per Share -$0.76
  • Revenue Per Share $0.01
  • Gross Profit -8107000
  • Quarterly Earnings Growth -71.4%
View More

Highlights

  • Market Capitalization 915.69 million
  • EBITDA -58497000
  • Analyst Target Price $6.6
  • Book Value Per Share $0.70
View More

Share Statistics

  • Shares Outstanding 254 million
  • Shares Float 177.44 million
  • % Held by Insiders 348%
  • % Held by Institutions 57.81%
  • Shares Short 40.82 million
  • Shares Short Prior Month 39.53 million
  • Short Ratio 4.5
  • Short % of Float 21%
  • Short % of Shares Outstanding 16%
View More

Technicals

  • Beta 1.99
  • 52 Week High $6.93
  • 52 Week Low $0.71
  • 50 Day Moving Average 3.54
  • 200 Day Moving Average 3.14
View More

Dividends

  • Dividend Date 2012-12-28
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

VBI Vaccines Inc (VBIV) Dividend Calendar:

VBIV's last dividend payment was made to shareholders on December 28, 2012.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

VBI Vaccines Inc (VBIV) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-02$164000-$0.06-$0.05-12.57%
2020-09-302020-11-02$298000-$0.06-$0.05-33.33%
2020-06-302020-07-31$N/A-$0.04-$0.040%
2020-03-312020-05-06$415000-$0.05-$0.0723.08%
2019-12-312020-03-05$574000-$0.02-$0.0665.22%
2019-09-302019-11-06$647000-$0.15-$0.13-20%
2019-06-302019-08-09$640000-$0.13-$0.147.14%
2019-03-312019-05-01$360000-$0.15-$0.150%
2018-12-312019-02-25$2.68 million-$0.28-$0.22-29.21%
2018-09-302018-11-09$259000-$0.24-$0.240%
2018-06-302018-07-26$234000-$0.26-$0.17-52.94%
2018-03-312018-05-01$178000-$0.19-$0.17-11.76%
2017-12-312018-02-26$201000-$0.20-$0.200%
2017-09-302017-11-13$193000-$0.24-$0.22-9.09%
2017-06-302017-07-31$344000-$0.22-$0.21-6.43%
2017-03-312017-05-15$127000-$0.22-$0.16-41.94%
2016-12-312017-03-20$137000-$0.23-$0.16-43.75%
2016-09-302016-11-09$281000-$0.20-$0.17-15.41%
2016-06-302016-08-15$82000-$0.23-$0.19-21.05%
2016-03-312016-05-13$48000-$0.06
2014-03-312014-03-31$498603-$0.32
2013-12-312013-12-31-$0.32
2013-09-302013-09-30-$0.22
2013-06-302013-06-30-$0.10
2013-03-312013-03-31-$0.09
2012-12-312012-12-31-$0.21
2012-09-302012-09-30-$0.68
2012-06-302012-06-30-$0.37
2012-03-312012-03-31-$0.62
2011-12-312011-12-31-$0.56
2011-09-302011-09-30-$0.70
2011-06-302011-06-30-$0.90
2011-03-312011-03-31-$7.23
2010-12-312010-12-31-$0.31
2010-09-302010-09-30-$1.80
2010-06-302010-06-30-$0.16
2010-03-312010-03-31-$0.26
2009-12-312009-12-31-$0.12
2009-09-302009-09-30-$0.06
2009-06-302009-06-30-$0.06
2008-12-312008-12-31-$0.05
2008-09-302008-09-30-$0.08
2008-06-302008-06-30-$0.05
2008-03-312008-03-31-$0.13
2007-12-312007-12-31-$0.15
2007-09-302007-09-30-$0.16
2007-06-302007-06-30-$0.07
2007-03-312007-03-31$0.00
2006-12-312006-12-31-$0.06
2006-09-302006-09-30-$0.10
2006-06-302006-06-30-$0.07
2006-03-312006-03-31-$0.34
2005-12-312005-12-31-$0.05
2005-09-302005-09-30-$0.07
2005-06-302005-06-30-$0.06
2005-03-312005-03-31$0.04
2004-12-312004-12-31-$0.03
2004-09-302004-09-30-$0.04
2004-06-302004-06-30-$0.04
2004-03-312004-03-31-$0.07
2003-12-312003-12-31-$0.13
2003-09-302003-09-30-$0.08
2003-06-302003-06-30-$0.08
2003-03-312003-03-31-$0.12
2002-12-312002-12-31-$0.02
2002-09-302002-09-30-$0.05
2002-06-302002-06-30-$0.03
2002-03-312002-03-31-$1.46
2001-12-312001-12-31-$0.03
2001-09-302001-09-30-$0.03
2001-06-302001-06-30-$0.05

VBI Vaccines Inc (VBIV) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

VBI Vaccines Inc (VBIV) Chart:

VBI Vaccines Inc (VBIV) News:

Below you will find a list of latest news for VBI Vaccines Inc (VBIV) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

VBI Vaccines Inc (VBIV) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest VBIV Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$0.6801
Jun 13, 2022 7:59 PM EST100$0.6801
Jun 13, 2022 7:59 PM EST100$0.6801
Jun 13, 2022 7:59 PM EST200$0.6801
Jun 13, 2022 7:59 PM EST147$0.6801

VBI Vaccines Inc (VBIV) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220012556/0001493152-20-012556-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/764195/000083423720008030/0000834237-20-008030-index.htm
2020-06-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/764195/000083423720009578/0000834237-20-009578-index.htm
2019-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000089924319024191/0000899243-19-024191-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000089924320011371/0000899243-20-011371-index.htm
2018-12-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/764195/000092189518003382/0000921895-18-003382-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/764195/000092189520000544/0000921895-20-000544-index.htm
2019-03-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/764195/000094480919000019/0000944809-19-000019-index.htm
2019-09-30SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/764195/000094480919000062/0000944809-19-000062-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000101297519000443/0001012975-19-000443-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000101297519000447/0001012975-19-000447-index.htm
2019-10-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/764195/000107261319000280/0001072613-19-000280-index.htm
2019-06-12SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/764195/000119312519171297/0001193125-19-171297-index.htm
2019-06-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/764195/000119312519177548/0001193125-19-177548-index.htm
2019-09-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/764195/000119312519256069/0001193125-19-256069-index.htm
2020-04-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/764195/000119312520122131/0001193125-20-122131-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315218017690/0001493152-18-017690-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315218017749/0001493152-18-017749-index.htm
2019-01-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219000670/0001493152-19-000670-index.htm
2019-01-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219000696/0001493152-19-000696-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219001328/0001493152-19-001328-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219001331/0001493152-19-001331-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219001334/0001493152-19-001334-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219001335/0001493152-19-001335-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219001336/0001493152-19-001336-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219001337/0001493152-19-001337-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219001340/0001493152-19-001340-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219001342/0001493152-19-001342-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219001344/0001493152-19-001344-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219001346/0001493152-19-001346-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219001347/0001493152-19-001347-index.htm
2019-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219001392/0001493152-19-001392-index.htm
2019-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219001686/0001493152-19-001686-index.htm
2019-02-2510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/764195/000149315219002481/0001493152-19-002481-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219002524/0001493152-19-002524-index.htm
2019-03-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219003575/0001493152-19-003575-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219004514/0001493152-19-004514-index.htm
2019-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219004841/0001493152-19-004841-index.htm
2019-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219005048/0001493152-19-005048-index.htm
2019-04-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219005191/0001493152-19-005191-index.htm
2019-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219005525/0001493152-19-005525-index.htm
2019-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219005829/0001493152-19-005829-index.htm
2019-04-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219005871/0001493152-19-005871-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219005873/0001493152-19-005873-index.htm
2019-04-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219005894/0001493152-19-005894-index.htm
2019-04-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219005992/0001493152-19-005992-index.htm
2019-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/764195/000149315219006075/0001493152-19-006075-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/764195/000149315219006076/0001493152-19-006076-index.htm
2019-05-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/764195/000149315219006225/0001493152-19-006225-index.htm
2019-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219006238/0001493152-19-006238-index.htm
2019-05-10DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/764195/000149315219006803/0001493152-19-006803-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219008650/0001493152-19-008650-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219009160/0001493152-19-009160-index.htm
2019-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219009279/0001493152-19-009279-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219009375/0001493152-19-009375-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219009377/0001493152-19-009377-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219009380/0001493152-19-009380-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219009381/0001493152-19-009381-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219009383/0001493152-19-009383-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219009422/0001493152-19-009422-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219009424/0001493152-19-009424-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219009492/0001493152-19-009492-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219009565/0001493152-19-009565-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219009942/0001493152-19-009942-index.htm
2019-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219011253/0001493152-19-011253-index.htm
2019-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219011590/0001493152-19-011590-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219011862/0001493152-19-011862-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/764195/000149315219011951/0001493152-19-011951-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219012016/0001493152-19-012016-index.htm
2019-08-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219012859/0001493152-19-012859-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219013728/0001493152-19-013728-index.htm
2019-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219013910/0001493152-19-013910-index.htm
2019-09-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/764195/000149315219014263/0001493152-19-014263-index.htm
2019-09-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/764195/000149315219014391/0001493152-19-014391-index.htm
2019-09-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219014392/0001493152-19-014392-index.htm
2019-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219014583/0001493152-19-014583-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219014759/0001493152-19-014759-index.htm
2019-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219014801/0001493152-19-014801-index.htm
2019-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219014802/0001493152-19-014802-index.htm
2019-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219014865/0001493152-19-014865-index.htm
2019-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315219015126/0001493152-19-015126-index.htm
2019-10-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219015848/0001493152-19-015848-index.htm
2019-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219015917/0001493152-19-015917-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/764195/000149315219016516/0001493152-19-016516-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219016518/0001493152-19-016518-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219016781/0001493152-19-016781-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219017546/0001493152-19-017546-index.htm
2019-11-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315219018204/0001493152-19-018204-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220000447/0001493152-20-000447-index.htm
2020-01-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220000595/0001493152-20-000595-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220001067/0001493152-20-001067-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220001071/0001493152-20-001071-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220001072/0001493152-20-001072-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220001078/0001493152-20-001078-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220001079/0001493152-20-001079-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220001087/0001493152-20-001087-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220001088/0001493152-20-001088-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220001089/0001493152-20-001089-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220001090/0001493152-20-001090-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220001092/0001493152-20-001092-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220003194/0001493152-20-003194-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220003250/0001493152-20-003250-index.htm
2020-03-0510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/764195/000149315220003413/0001493152-20-003413-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220003421/0001493152-20-003421-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220003866/0001493152-20-003866-index.htm
2020-03-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220004039/0001493152-20-004039-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220004653/0001493152-20-004653-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220005406/0001493152-20-005406-index.htm
2020-04-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/764195/000149315220006841/0001493152-20-006841-index.htm
2020-04-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/764195/000149315220007010/0001493152-20-007010-index.htm
2020-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220007012/0001493152-20-007012-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220007113/0001493152-20-007113-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/764195/000149315220007261/0001493152-20-007261-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/764195/000149315220007264/0001493152-20-007264-index.htm
2020-05-01DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220007484/0001493152-20-007484-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/764195/000149315220007781/0001493152-20-007781-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220007783/0001493152-20-007783-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220008986/0001493152-20-008986-index.htm
2020-05-27DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220009917/0001493152-20-009917-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220009938/0001493152-20-009938-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220010122/0001493152-20-010122-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220011319/0001493152-20-011319-index.htm
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220011562/0001493152-20-011562-index.htm
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220011569/0001493152-20-011569-index.htm
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220012545/0001493152-20-012545-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220012548/0001493152-20-012548-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220012550/0001493152-20-012550-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220012552/0001493152-20-012552-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220012553/0001493152-20-012553-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220012555/0001493152-20-012555-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/764195/000149315220012556/0001493152-20-012556-index.htm
2020-07-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/764195/000149315220014278/0001493152-20-014278-index.htm
2020-07-31S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/764195/000149315220014355/0001493152-20-014355-index.htm
2020-07-31S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/764195/000149315220014358/0001493152-20-014358-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220014448/0001493152-20-014448-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220014680/0001493152-20-014680-index.htm
2020-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220016492/0001493152-20-016492-index.htm
2020-08-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220016722/0001493152-20-016722-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220016973/0001493152-20-016973-index.htm
2020-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220017703/0001493152-20-017703-index.htm
2020-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220017960/0001493152-20-017960-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220018052/0001493152-20-018052-index.htm
2020-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220018256/0001493152-20-018256-index.htm
2020-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220019193/0001493152-20-019193-index.htm
2020-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220019471/0001493152-20-019471-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220019917/0001493152-20-019917-index.htm
2020-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/764195/000149315220020276/0001493152-20-020276-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/764195/000149315220020291/0001493152-20-020291-index.htm
2019-03-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/764195/999999999719000921/9999999997-19-000921-index.htm

VBI Vaccines Inc (VBIV) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of VBI Vaccines Inc (VBIV). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 348%
Institutional Ownership: 5781%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-10-04Francisco Diaz-MitomaChief Medical OfficerBuy40,000.000.5020,000.00117,500.00https://www.sec.gov/Archives/edgar/data/764195/000149315219015126/0001493152-19-015126-index.htm
2019-01-31David Evander AndersonChief Scientific OfficerBuy25,000.00126,334.00https://www.sec.gov/Archives/edgar/data/764195/000149315219001331/0001493152-19-001331-index.htm
2019-09-30Francisco Diaz-MitomaChief Medical OfficerBuy14,500.000.507,250.0014,500.00https://www.sec.gov/Archives/edgar/data/764195/000149315219015126/0001493152-19-015126-index.htm
2019-06-14David Evander AndersonChief Scientific OfficerBuy21,875.00148,209.00https://www.sec.gov/Archives/edgar/data/764195/000149315219009380/0001493152-19-009380-index.htm
2019-01-31Avi MazaltovHead Global MFG&GM-SciVac Ltd.Buy90,000.00196,000.00https://www.sec.gov/Archives/edgar/data/764195/000149315219001334/0001493152-19-001334-index.htm
2019-06-17PERCEPTIVE ADVISORS LLC10% Share HolderBuy1,000,000.000.62618,000.0024,951,556.00https://www.sec.gov/Archives/edgar/data/764195/000101297519000443/0001012975-19-000443-index.htm
2019-01-31Christopher McNultyCFO and Head of BDBuy25,000.0025,000.00https://www.sec.gov/Archives/edgar/data/764195/000149315219001336/0001493152-19-001336-index.htm
2019-06-18PERCEPTIVE ADVISORS LLC10% Share HolderBuy1,000,000.000.65650,000.0025,951,556.00https://www.sec.gov/Archives/edgar/data/764195/000101297519000447/0001012975-19-000447-index.htm
2019-06-20Francisco Diaz-MitomaChief Medical OfficerBuy10,000.000.787,800.0027,500.00https://www.sec.gov/Archives/edgar/data/764195/000149315219009492/0001493152-19-009492-index.htm
2019-01-31Jeff BaxterCEO, PresidentBuy50,000.00283,005.00https://www.sec.gov/Archives/edgar/data/764195/000149315219001340/0001493152-19-001340-index.htm
2019-06-14Jeff BaxterCEO, PresidentBuy31,250.00314,255.00https://www.sec.gov/Archives/edgar/data/764195/000149315219009383/0001493152-19-009383-index.htm
2019-01-31Nell BeattieChief Business OfficerBuy15,000.0035,750.00https://www.sec.gov/Archives/edgar/data/764195/000149315219001328/0001493152-19-001328-index.htm
2019-10-01Christopher McNultyCFO and Head of BDBuy12,000.000.475,676.0037,000.00https://www.sec.gov/Archives/edgar/data/764195/000149315219014802/0001493152-19-014802-index.htm
2019-06-14Nell BeattieChief Business OfficerBuy6,250.0042,000.00https://www.sec.gov/Archives/edgar/data/764195/000149315219009375/0001493152-19-009375-index.htm
2019-06-19Jeff BaxterCEO, PresidentBuy144,000.000.73105,336.00458,255.00https://www.sec.gov/Archives/edgar/data/764195/000149315219009422/0001493152-19-009422-index.htm
2019-09-23PERCEPTIVE ADVISORS LLC10% Share HolderBuy20,000,000.000.5010,000,000.0045,951,556.00https://www.sec.gov/Archives/edgar/data/764195/000089924319024191/0000899243-19-024191-index.htm
2019-06-14Michel DeWildeDirectorBuy12,500.0050,000.00https://www.sec.gov/Archives/edgar/data/764195/000149315219009377/0001493152-19-009377-index.htm
2019-06-19Nell BeattieChief Business OfficerBuy8,000.000.745,885.6050,000.00https://www.sec.gov/Archives/edgar/data/764195/000149315219009424/0001493152-19-009424-index.htm
2020-04-24PERCEPTIVE ADVISORS LLC10% Share HolderBuy9,090,909.001.109,999,999.9055,042,456.00https://www.sec.gov/Archives/edgar/data/764195/000089924320011371/0000899243-20-011371-index.htm
2019-10-01Nell BeattieChief Business OfficerBuy10,000.000.484,822.0060,000.00https://www.sec.gov/Archives/edgar/data/764195/000149315219014801/0001493152-19-014801-index.htm
2019-09-30Jeff BaxterCEO, PresidentBuy150,000.000.5075,450.00608,255.00https://www.sec.gov/Archives/edgar/data/764195/000149315219014759/0001493152-19-014759-index.htm
2019-06-20Francisco Diaz-MitomaChief Medical OfficerBuy42,000.000.8937,380.0069,500.00https://www.sec.gov/Archives/edgar/data/764195/000149315219009492/0001493152-19-009492-index.htm
2019-06-27Francisco Diaz-MitomaChief Medical OfficerBuy8,000.001.078,560.0077,500.00https://www.sec.gov/Archives/edgar/data/764195/000149315219009942/0001493152-19-009942-index.htm
2019-06-14STEVEN GILLISDirectorBuy18,750.0084,416.00https://www.sec.gov/Archives/edgar/data/764195/000149315219009381/0001493152-19-009381-index.htm